When we used AFP to separate HBV-HCC patients from HBV-infected patients, the AUC was 0.584 (95% CI: 0.456-0.713), the sensitivity was 75.0%, and the specificity was 65.5%. The gene discussed is AFP; the disease is hepatocellular carcinoma.